HealthCare Global Enterprises Limited (NSE:HCG)

Market Cap	106.39B +10.0%
Revenue (ttm)	26.27B +13.7%
Net Income	227.80M -38.6%
EPS	1.57 -40.1%
Shares Out	149.30M
PE Ratio	467.01
Forward PE	65.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	123,628
Open	692.90
Previous Close	690.60
Day's Range	688.00 - 715.65
52-Week Range	513.30 - 804.65
Beta	-0.03
Analysts	Strong Buy
Price Target	806.80 (+13.23%)
Earnings Date	Nov 12, 2026

About NSE:HCG

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 6,761
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: HCG

Financial Performance

In fiscal year 2026, NSE:HCG's revenue was 25.45 billion, an increase of 14.51% compared to the previous year's 22.23 billion. Earnings were 137.55 million, a decrease of -69.03%.

Analyst Summary

According to 10 analysts, the average rating for HCG stock is "Strong Buy." The 12-month stock price target is ₹806.80, which is an increase of 13.23% from the latest price.

Price Target

₹806.80

(13.23% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 9, 2026

Data Sources Report a data error